PRISMqd is a predictive patient safety ecosystem that unites expanded physiologic monitoring, real-time clinical decision support, and closed-loop escalation — across hospital, sub-acute, and home.
From Risk to Rescue
Failure to Rescue — the preventable death or injury of a patient whose deterioration was not recognized and acted upon in time — is the leading cause of avoidable hospital mortality worldwide. Conservative estimates cite 400,000 reported deaths annually in the U.S. alone. Studies consistently show up to 60% of cases go unreported. The actual toll is closer to one million Americans each year.
FTR does not happen only in ICUs. It happens on surgical floors, in long-term care facilities, after discharge, and inside psychiatric units. It happens when monitoring is fragmented, escalation is suppressed, and the clinician at the bedside has no objective data to back what their clinical instincts already know.
"I was the rapid response nurse in six of the six case studies that form PRISMqd's clinical foundation. In Case A, I arrived after a missed stroke protocol led to a catastrophic bleed. In Case B, I watched a hospitalist dismiss objective deterioration because there was no data to prove what every clinician in the room could see. In the cardiac case, I refused an unsafe assignment for a fresh post-arrest patient, escalated through every available channel, and reported the institution externally. I built PRISMqd because the technology that should have existed in every one of those moments did not."
All cases documented by Jennifer Torrez, BSN, RN as responding rapid response nurse.
PRISMqd is a predictive patient safety ecosystem that unites expanded physiologic monitoring, real-time clinical decision support, and closed-loop escalation into a single, auditable layer across the care continuum — hospital, sub-acute, and home.
Sensor miniaturization, edge AI, and cloud-scale HIPAA infrastructure have converged at the exact moment that healthcare systems are under maximum pressure to reduce preventable harm costs. PRISMqd is positioned at that intersection — with clinical credibility, working prototypes, and a committed pilot site.
PRISMqd is currently raising a $1.5M pre-seed equity round. If you're an investor, clinical partner, or strategic advisor interested in learning more, we'd like to hear from you.
Fill out the form and Jennifer will be in touch directly — typically within 24 hours.